Glycemic variability assessed by continuous glucose monitoring in hospitalized patients with community-acquired pneumonia

被引:13
作者
Olsen, Mikkel Thor [1 ]
Dungu, Arnold Matovu [2 ]
Klarskov, Carina Kirstine [1 ]
Jensen, Andreas Kryger [4 ,5 ]
Lindegaard, Birgitte [2 ,3 ]
Kristensen, Peter Lommer [1 ,3 ]
机构
[1] Copenhagen Univ Hosp North Zealand, Dept Endocrinol & Nephrol, Hillerod, Denmark
[2] Copenhagen Univ Hosp North Zealand, Dept Pulm & Infect Dis, Hillerod, Denmark
[3] Copenhagen Univ Hosp North Zealand, Fac Hlth & Med Sci, Dept Clin Med, Hillerod, Denmark
[4] Univ Copenhagen, Dept Publ Hlth, Biostat, Oster Farimagsgade 5, DK-1014 Copenhagen, Denmark
[5] Copenhagen Univ Hosp North Zealand, Dept Clin Res, Hillerod, Denmark
关键词
Chronic obstructive pulmonary disease; Community-acquired pneumonia; Continuous glucose monitoring; Diabetes mellitus; Glucocorticoid-induced hyperglycemia; Glycemic variability; Length of stay; LENGTH-OF-STAY; MORTALITY; OUTCOMES; HYPERGLYCEMIA; IMPACT;
D O I
10.1186/s12890-022-01874-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Glycemic variability (GV) has only been sparsely studied in patients with community-acquired pneumonia (CAP). This study aimed to quantify in-hospital GV in CAP patients, including determining the impact of type 2 diabetes mellitus (T2DM) and glucocorticoid (GC) treatment on GV. Methods This is a prospective cohort study of CAP patients (N = 40) with or without T2DM and treated or not with GCs. The primary endpoint was GV measured as glucose standard deviation (SD), coefficient of variation (CV), and postprandial glucose excursions (PPGE) based on continuous glucose monitoring (CGM). Analysis of glucose data was split into daytime and nighttime when possible. Results Patients included had a mean age of 74 (range 55 to 91) years. SD (95%CI) increased by a factor of 1.93 (1.40 to 2.66) and 2.29 (1.38 to 3.81) in patients with T2DM and not treated with GCs during the daytime and the nighttime, respectively (both P < 0.01), and by a factor of 1.42 (1.04 to 1.97) in patients treated with GCs but without T2DM during the daytime (P = 0.031) compared to patients without T2DM and not treated with GCs. CV (95%CI) increased by 5.1 (0.0 to 10.1) and 8.1 (1.0 to 15.2) percentage points during the daytime and the nighttime, respectively, in patients with T2DM and not treated with GCs compared to patients without T2DM and not treated with GCs (P = 0.046 and P = 0.026, respectively). PPGE (95% CI) increased during lunch by 2.5 (0.7 to 4.3) mmol/L (45 (13 to 77) mg/dL) in patients with T2DM and treated with GCs compared to patients without T2DM and not treated with GCs (P = 0.018). Conclusions CAP patients receiving GCs, especially those with T2DM, are at great risk of developing high GV and therefore require clinical attention to mitigate GV. This applies particularly during the daytime. Results support the 1 to 2-h post-lunch screening procedure for glucocorticoid-induced hyperglycemia in patients without diabetes. SD was positively correlated with hospital length of stay.
引用
收藏
页数:13
相关论文
共 43 条
  • [1] A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
    Aberer, Felix
    Hochfellner, Daniel A.
    Sourij, Harald
    Mader, Julia K.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (10)
  • [2] High Glucose Variability Increases Mortality Risk in Hospitalized Patients
    Akirov, Amit
    Diker-Cohen, Talia
    Masri-Iraqi, Hiba
    Shimon, Ilan
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (07) : 2230 - 2241
  • [3] Pulmonary Function Tests in Type 2 Diabetics and Non-Diabetic People -A Comparative Study
    Aparna, A.
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (08) : 1606 - 1608
  • [4] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
    Battelino, Tadej
    Danne, Thomas
    Bergenstal, Richard M.
    Amiel, Stephanie A.
    Beck, Roy
    Biester, Torben
    Bosi, Emanuele
    Buckingham, Bruce A.
    Cefalu, William T.
    Close, Kelly L.
    Cobelli, Claudio
    Dassau, Eyal
    DeVries, J. Hans
    Donaghue, Kim C.
    Dovc, Klemen
    Doyle, Francis J.
    Garg, Satish
    Grunberger, George
    Heller, Simon
    Heinemann, Lutz
    Hirsch, Irl B.
    Hovorka, Roman
    Jia, Weiping
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Levine, Brian
    Mayorov, Alexander
    Mathieu, Chantal
    Murphy, Helen R.
    Nimri, Revital
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Rodbard, David
    Saboo, Banshi
    Schatz, Desmond
    Stoner, Keaton
    Urakami, Tatsuiko
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2019, 42 (08) : 1593 - 1603
  • [5] Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
    Blum, Claudine Angela
    Nigro, Nicole
    Briel, Matthias
    Schuetz, Philipp
    Ullmer, Elke
    Suter-Widmer, Isabelle
    Winzeler, Bettina
    Bingisser, Roland
    Elsaesser, Hanno
    Drozdov, Daniel
    Arici, Birsen
    Urwyler, Sandrine Andrea
    Refardt, Julie
    Tarr, Philip
    Wirz, Sebastian
    Thomann, Robert
    Baumgartner, Christine
    Duplain, Herve
    Burki, Dieter
    Zimmerli, Werner
    Rodondi, Nicolas
    Mueller, Beat
    Christ-Crain, Mirjam
    [J]. LANCET, 2015, 385 (9977) : 1511 - 1518
  • [6] Continuous Monitoring of Circadian Glycemic Patterns in Patients Receiving Prednisolone for COPD
    Burt, Morton G.
    Roberts, Gregory W.
    Aguilar-Loza, Norma R.
    Frith, Peter
    Stranks, Stephen N.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (06) : 1789 - 1796
  • [7] International Consensus on Use of Continuous Glucose Monitoring
    Danne, Thomas
    Nimri, Revital
    Battelino, Tadej
    Bergenstal, Richard M.
    Close, Kelly L.
    DeVries, J. Hans
    Garg, Satish
    Heinemann, Lutz
    Hirsch, Irl
    Amiel, Stephanie A.
    Beck, Roy
    Bosi, Emanuele
    Buckingham, Bruce
    Cobelli, Claudio
    Dassau, Eyal
    Doyle, Francis J., III
    Heller, Simon
    Hovorka, Roman
    Jia, Weiping
    Jones, Tim
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Maahs, David
    Murphy, Helen R.
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Saboo, Banshi
    Scharf, Mauro
    Tamborlane, William V.
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2017, 40 (12) : 1631 - 1640
  • [8] Clinical Features, Etiology, and Outcomes of Community-Acquired Pneumonia in Patients With Diabetes Mellitus
    Di Yacovo, Silvana
    Garcia-Vidal, Carolina
    Viasus, Diego
    Adamuz, Jordi
    Oriol, Isabel
    Gili, Francesca
    Vilarrasa, Nuria
    Dolors Garcia-Somoza, M.
    Dorca, Jordi
    Carratala, Jordi
    [J]. MEDICINE, 2013, 92 (01) : 42 - 50
  • [9] Diabetes.co.uk-the global diabetes community, 2019, CONV HBA1C AV BLOOD
  • [10] Stress hyperglycaemia
    Dungan, Kathleen M.
    Braithwaite, Susan S.
    Preiser, Jean-Charles
    [J]. LANCET, 2009, 373 (9677) : 1798 - 1807